Literature DB >> 29383222

Zika virus infection in a pediatric patient with acute gastrointestinal involvement.

Svetoslav Slavov1,2, Alessandra Matsuno3, Aparecida Yamamoto3, Katia Otaguiri1,4, Maria Cervi3, Dimas Covas1,2, Simone Kashima1,4.   

Abstract

Entities:  

Keywords:  ZIKV; Zika virus; abdominal pain; viral load

Year:  2018        PMID: 29383222      PMCID: PMC5768094          DOI: 10.4081/pr.2017.7341

Source DB:  PubMed          Journal:  Pediatr Rep        ISSN: 2036-749X


× No keyword cloud information.

Competing interest statement

Conflict of interest: the authors declare no conflict of interest.

Abstract

Zika virus (ZIKV) is a mosquito-borne flavivirus, which has been related to severe neurological complications in neonates. However, many clinical aspects of the infection remain unclear, especially in pediatric patients. In this case report we describe the uncommon presentation of ZIKV infection in a pediatric patient with acute gastrointestinal involvement hospitalized in a Brazilian Emergency Unit. Dengue hemorrhagic fever was initially suspected, however, the molecular result for Dengue was negative. Molecular testing for other arboviruses (ZIKV and Chikungunya), revealed positive for ZIKV RNA result in both blood and saliva. The ZIKV load in saliva (6.947 copies/mL) was higher than the vetected ZIKV RNA in plasma (1.945 copies/mL). Additionally, the performed abdominal ultrasound revealed mesenteric lymphadenitis without abdominal retention of fluids. The presentation of this case demonstrates that ZIKV can be involved in a broader range of clinical conditions than currently assumed, including pediatric emergencies, especially in regions with extensive ZIKV outbreaks.

Introduction

Zika virus (ZIKV) is a mosquito-borne flavivirus that has been causing a large outbreak in Brazil since 2014.[1] Although the impact of the infection on pediatric patients is critical due to the relationship between ZIKV and fetal neurological and ocular abnormalities,[2,3] the majority of the infected individuals demonstrate benign febrile condition accompanied by rash, myalgia, and/or conjunctivitis.[4] Still, many aspects of ZIKV infection remain unclear and it is possible that the virus may be involved in a broader clinical spectrum than currently assumed.

Case Report

A male pediatric patient at eight years of age was admitted on March, 29th, 2016 to the Emergency Unit of the University Hospital, Faculty of Medicine of Ribeirão Preto, University of São Paulo, city of Ribeirão Preto, São Paulo State, Brazil, with six day history of repetitive high fever for ~four times a day (38.5-39°C), accompanied by frontal headache, retro-orbital pain, photo- and phonophobia. The retrospective clinical history demonstrated that five days before the hospitalization, the patient presented severe myalgia of the whole body, especially in the legs and was treated with antipyretic drugs. At the time of hospitalization (day #1), diffuse abdominal pain without precise location and two vomiting episodes were registered. The patient denied rash or conjunctivitis. The physical examination demonstrated stable general condition, paleness, no jaundice, adequate hydration status, and eupnea. The skin was without active maculopapular lesions, the respiratory frequency was 28 ipm, heart frequency 110 bpm, blood pressure 109×74 mmHg, and 98% oxygen saturation by pulse oximetry in ambient air. Pulmonary and cardiac examinations showed no changes, except moderate to severe diffuse abdominal pain during palpation. Neurological examination was without meningeal signs, only a mild somnolence was observed. All laboratory parameters were within the normal range, excluding the C-reactive protein, which was highly elevated (11.2 mg/L, high >0.5 mg/L) (Table 1).
Table 1.

Biochemical and hematologic parameters of the Zika virus infected pediatric patient during hospitalization.

Clinical parametersDays during hospital hospitalization
 Day #1Day #2Day #3Day #4
Alanine Transaminase (IU/L)3316N/AN/A
Aspartase Transaminase3333NAN/A
Creatinine (mg/dL)0.5N/AN/AN/A
C-reactive protein (mg/dL)N/AN/A11.28.34
Serum ionic calcium (mg/dL)N/AN/A1.2N/A
Serum potassium (mg/dL)N/A54.6N/A
Serum sodium (mg/dL)N/A133133N/A
Platelets (×103, cells/mm3)216195185249
White blood cells (×103, cells/mm3)8.128.749.207.30
Hematocrit (%)33.730.640.034.0
Hemoglobin (g/dL)11.810.813.111.0

N/A, not available.

Because of ongoing dengue virus (DENV) outbreak by this time in our region, the abdominal pain and the rising hematocrit (33.7% at day #2 to 40.0% at day #4), the medical staff suspected DENV hemorrhagic fever (DHF). Therefore, intravenous hydration was started immediately following well-established DHF-prevention protocol with gradual improvement of the hematocrit. On day #2 of hospitalization (March, 30th), due to the persistent severe abdominal pain and vomiting, the patient was submitted to abdominal ultrasound which showed mesenteric adenitis without fluid leakage in the abdominal cavity (Figure 1). Chest X-ray showed no pulmonary abnormalities. The diagnosis of the mesenteric adenitis was based on the radiologic detection of three or more lymphonodes with at least 5 mm of short-axis diameter in the right lower quadrant, as described previously.[5,6]
Figure 1.

Radiological findings.

At the same day (day #2), in order to diagnose DENV, whole blood was collected and viral RNA was extracted using QIAamp Viral RNA Mini Kit (QIAGEN, São Paulo, Brazil) following the manufacturer´s instructions. DENV TaqMan® real-time PCR was performed with primers and probe detecting all serotypes.[7] The PCR result for DENV was negative. Once in the region cocirculated also ZIKV and Chikungunya (CHIKV), the sample was simultaneously quantified for these arboviruses. The detection and quantification of both viruses was performed using primers and probes found in the literature.[8,9] CHIKV quantification demonstrated a negative result. However, ZIKV detection in blood generated a positive amplification with viral load of 1,945 copies/mL. In order to further confirm ZIKV infection, on day #3 of hospitalization a saliva swab was required for viral quantification. The saliva also demonstrated a positive result for ZIKV RNA with higher than plasma viral load (6,947 copies/mL). The patient samples were negative for Influenza, Adenovirus, Epstein-Barr and Cytome galovirus. The patient demonstrated favorable evolution, however, once the fever persisted for two more days, his discharge was delayed and hospitalization was continued for more 5 days. On day #8, the patient was discharged without fever and in good general health. Nevertheless, on day #14 he returned with fever and headache and was diagnosed with sinusitis based on a standard othorhinological examination. Treatment with amoxycilin 50 mg/kg/day improved the condition on day#17.

Discussion

In this case report, we demonstrate the detection of ZIKV RNA in blood and saliva of a pediatric patient with acute gastrointestinal involvement. This finding was registered during an extensive DENV/ZIKV outbreak in the region (Ribeirão Preto city is located in the Northeast part of the São Paulo State, Southeast Brazil, 21°10’40’’S 47°48’36’’E) and demonstrates the possibility of ZIKV to be involved in a wider range of clinical manifestations than already suggested, [2,4] including acute pediatric conditions. In this patient, ZIKV infection was related to gastrointestinal involvement accompanied by mesenteric adenitis (Figure 1) and localized myalgia without exanthema. ZIKV RNA was detected in both plasma and saliva. Salivary ZIKV excretion has been demonstrated by previous studies[10] and it seems a promising noninvasive ZIKV diagnostic tool in emergency room pediatric patients._ The presented case demonstrated atypical presentation of clinically overt ZIKV infection in the affected child with gastrointestinal involvement. Once the infection was associated with mesenteric adenitis, it seems that ZIKV should be contemplated in the differential diagnosis of acute abdominal pain observed frequently in pediatric emergencies. Although in rare cases DENV infection can also lead from moderate to severe abdominal pain, the pathogenesis of DENV abdominal involvement is unclear. One of the possible explanations includes plasma leakage with vascular damage.[11] In our case, we believe that the acute abdominal pain with probable ZIKV etiology was related to an inflammatory process as judged by the enlarged mesenteric lymphonodes without abdominal retention of fluids observed by abdominal ultrasound (Figure 1), and the elevated C-reactive protein. Another important consideration related to the clinical evolution of this patient was the development of sinusitis, which was diagnosed 10 days after the molecular confirmation of ZIKV. Currently, it is unknown whether ZIKV infection may be associated with secondary bacterial infections. However, in adult patients with confirmed DENV fever, Trunfio et al. (2016), demonstrated between 0.18 and 7.0% prevalence of bacterial coinfections. The mechanism which leads to secondary bacterial invasion in DENV is unknown.[12] It can be hypothesized that multiple factors including: i) the neutropenia associated with DENV fever; ii) bacterial translocation due to increased intestinal vascular leakage; and/or iii) breakdown of the skin barrier caused by intense itching of the exanthema are involved. Our patient did not show any of the above mentioned signs and therefore, we suppose that the origin of the bacterial sinusitis in ZIKV may have different immunopathogenesis or might be an occasional finding without relationship to ZIKV infection. However, more studies are needed in order to investigate the immunomodulation during acute ZIKV infection in pediatric patients.

Conclusions

In this case report we describe ZIKV infection in a pediatric patient with abdominal mesenteric inflammation hospitalized in the emergency room. The clinical aspects of this case were compatible mainly with gastrointestinal involvement without exanthema. We therefore believe that ZIKV should be considered in the differential diagnosis of acute abdominal pain in pediatric patients, which is one of the most common complaints during acute pediatric emergencies.
  12 in total

1.  Mesenteric adenitis: CT diagnosis of primary versus secondary causes, incidence, and clinical significance in pediatric and adult patients.

Authors:  Michael Macari; John Hines; Emil Balthazar; Alec Megibow
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

2.  Dengue hemorrhagic fever patients with acute abdomen: clinical experience of 14 cases.

Authors:  Boon-Siang Khor; Jien-Wei Liu; Ing-Kit Lee; Kuender D Yang
Journal:  Am J Trop Med Hyg       Date:  2006-05       Impact factor: 2.345

3.  Zika: neurological and ocular findings in infant without microcephaly.

Authors:  Camila V Ventura; Mauricio Maia; Natalia Dias; Liana O Ventura; Rubens Belfort
Journal:  Lancet       Date:  2016-06-07       Impact factor: 79.321

Review 4.  Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere.

Authors:  Helen M Lazear; Michael S Diamond
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

5.  Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology.

Authors:  Eili Huhtamo; Essi Hasu; Nathalie Y Uzcátegui; Elina Erra; Simo Nikkari; Anu Kantele; Olli Vapalahti; Heli Piiparinen
Journal:  J Clin Virol       Date:  2009-12-05       Impact factor: 3.168

Review 6.  Bacterial coinfections in dengue virus disease: what we know and what is still obscure about an emerging concern.

Authors:  Mattia Trunfio; Alessia Savoldi; Ottavia Viganò; Antonella d'Arminio Monforte
Journal:  Infection       Date:  2016-07-22       Impact factor: 3.553

Review 7.  Evaluating the Patient with Right Lower Quadrant Pain.

Authors:  Neel B Patel; Daniel R Wenzke
Journal:  Radiol Clin North Am       Date:  2015-08-13       Impact factor: 2.303

8.  First report of autochthonous transmission of Zika virus in Brazil.

Authors:  Camila Zanluca; Vanessa Campos Andrade de Melo; Ana Luiza Pamplona Mosimann; Glauco Igor Viana Dos Santos; Claudia Nunes Duarte Dos Santos; Kleber Luz
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-06-09       Impact factor: 2.743

9.  Chikungunya virus in US travelers returning from India, 2006.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Amanda J Panella; Jason O Velez; Amy J Lambert; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more
  4 in total

1.  Postnatally Acquired Zika Virus Disease Among Children, United States, 2016-2017.

Authors:  Nicole P Lindsey; Charsey C Porse; Emily Potts; Judie Hyun; Kayleigh Sandhu; Elizabeth Schiffman; Kimberly B Cervantes; Jennifer L White; Krystal Mason; Kamesha Owens; Caroline Holsinger; Marc Fischer; J Erin Staples
Journal:  Clin Infect Dis       Date:  2020-01-02       Impact factor: 9.079

2.  ZIKV Infection Induces DNA Damage Response and Alters the Proteome of Gastrointestinal Cells.

Authors:  Kathleen Glover; Kevin M Coombs
Journal:  Viruses       Date:  2020-07-17       Impact factor: 5.048

3.  Gut microbiota modulation induced by Zika virus infection in immunocompetent mice.

Authors:  Rafael Corrêa; Igor de Oliveira Santos; Heloísa Antoniella Braz-de-Melo; Lívia Pimentel de Sant'Ana; Raquel das Neves Almeida; Gabriel Pasquarelli-do-Nascimento; Paulo Sousa Prado; Gary P Kobinger; Corinne F Maurice; Kelly Grace Magalhães
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

4.  Postnatal symptomatic Zika virus infections in children and adolescents: A systematic review.

Authors:  Anna Ramond; Ludmila Lobkowicz; Nuria Sanchez Clemente; Aisling Vaughan; Marília Dalva Turchi; Annelies Wilder-Smith; Elizabeth B Brickley
Journal:  PLoS Negl Trop Dis       Date:  2020-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.